GlassScriptPhysician profile
Jeffrey T Nelson
NPI 1730382813
$27,562.97
in general payments reported to CMS, 2019-2025
42 companies · $4,290 in 2025
The $4,290 reported for 2025 was more than what 97% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,643 · 2020: $3,100 · 2021: $6,234 · 2022: $6,105 · 2023: $3,506 · 2024: $685 · 2025: $4,290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,271 · Food and Beverage: $2,212 · Education: $1,599 · Travel and Lodging: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,271.00 |
| Food and Beverage | $2,212.45 |
| Education | $1,599.00 |
| Travel and Lodging | $399.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $13,037.55 | 2021-2025 | Nexplanon |
| Aesculap, INC. | $5,901.13 | 2019-2020 | |
| Intuitive Surgical, INC. | $1,902.53 | 2025 | |
| Merck Sharp & Dohme LLC | $1,513.92 | 2019-2021 | |
| Scynexis, INC. | $1,174.13 | 2022 | |
| Abbvie INC. | $938.27 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $595.39 | 2023-2025 | Myfembree |
| Pfizer INC. | $307.36 | 2021-2025 | |
| Astellas Pharma US INC | $213.30 | 2023-2025 | Veozah, Myrbetriq |
| Millicent US INC | $175.15 | 2023-2024 | Intrarosa, Femring |
| Mayne Pharma Commercial LLC | $154.73 | 2021-2025 | |
| Myovant Sciences INC. | $142.88 | 2021-2022 | |
| Exact Sciences Corporation | $135.16 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $124.05 | 2021-2024 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $117.37 | 2020-2025 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $105.36 | 2019-2022 | |
| Ascend Therapeutics US, LLC | $101.34 | 2021 | |
| Ethicon US, LLC | $89.92 | 2019-2025 | Stratafix, Echelon; Endopath, Surgicel Nu-Knit |
| Minerva Surgical, INC | $72.44 | 2021-2024 | |
| Hologic Sales and Service, LLC | $71.20 | 2020-2025 | Thinprep 2000 Processor, Aptima |
| Medtronic, INC. | $63.06 | 2023-2025 | Signia, Ligasure |
| Exeltis, USA INC. | $60.34 | 2023 | Slynd |
| Amag Pharmaceuticals, INC. | $47.03 | 2019-2020 | |
| Meditrina | $43.49 | 2022-2025 | |
| Mylan Pharmaceuticals INC. | $41.15 | 2021-2022 | |
| Mycovia Pharmaceuticals, INC. | $40.78 | 2022-2023 | Vivjoa |
| Allergan, INC. | $39.59 | 2019 | |
| Evofem Biosciences, INC. | $37.17 | 2021-2022 | |
| Coopersurgical, INC. | $35.43 | 2022-2023 | Mara Console |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.90 | 2021-2022 | |
| Specialty Surgical Instrumentation | $28.08 | 2021 | |
| Gynesonics, INC. | $26.45 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Duchesnay USA Incorporated | $24.29 | 2019 | |
| Sage Therapeutics, LLC | $24.25 | 2025 | Zurzuvae |
| Shield Therapeutics INC | $23.52 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.04 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $19.96 | 2019 | |
| Optumhealth Care Solutions, LLC | $19.43 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Agile Therapeutics, INC. | $17.44 | 2024 | Twirla |
| Lupin INC. | $16.05 | 2021 | |
| Axonics, INC. | $14.76 | 2023 | Bulkamid |
| Avion Pharmaceuticals | $12.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.